MedTrace Logo

Clinical Investigation of Sensovisc

NCT07237711 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2025-11-20

No results posted yet for this study

Summary

This clinical investigation aims to investigate the safety and performance of Sensovisc.

Sensovisc is used to reduce osteoarthritis (OA) related pain in the joints by supporting synovial fluid by intra-articular injection and allowing the synovial fluid to restore its viscoelastic properties. It increases the joint mobility by reducing or eliminating the pain.

This Clinical Investigation was designed as a cross-sectional, interventional, and prospective study.

Conditions

  • Osteo Arthritis of the Knee

Interventions

DEVICE

Sensovisc®

Injectable Sterile Sodium Hyaluronate Gel

Sponsors & Collaborators

  • İstem Medikal Tıbbi Cihaz ve Sanayi Ticaret Anonim Şirketi

    collaborator UNKNOWN

  • Ankara City Hospital Bilkent

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-25
Primary Completion
2026-08-25
Completion
2026-11-25

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07237711 on ClinicalTrials.gov